Clinical Trial

Tailoring an Online Platform to Promote Evidence-Based Care for Adults With Neurofibromatosis 1 and Low Health Literacy

Recruiting
View on ClinicalTrials.gov →
Summary
This decentralized, randomized study seeks to assess the feasibility, acceptability, and preliminary effectiveness of two approaches to assisting Neurofibromatosis 1 (NF1) patients with low health literacy improve their understanding of NF1 symptoms and care recommendations. Participants will be provided with personalized NF1 care letters for themselves and their doctors, along with either NF1 educational videos or a call with an NF1 peer navigator. Adults with NF1 from across the U.S. who have upcoming annual wellness visits scheduled with a primary care provider (PCP) are eligible to enroll in the study. To see if you might be eligible, fill out a prescreening survey here: https://redcap.link/nfpeer
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-05-30 -> 2027-05-30 2026-07-16
minor Completion pushed: 2026-05-30 -> 2027-05-30 2026-07-16
Trial Details
NCT Number NCT07233408
Lead Sponsor Massachusetts General Hospital
Collaborators: United States Department of Defense
Conditions Neurofibromatosis 1
Enrollment 50 participants
Start Date 2025-12-28
Primary Completion 2027-05-30 (estimated)
Study Completion 2027-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-15